The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Shared decision-making tools for patients with hematologic malignancies.
 
Thomas William LeBlanc
Honoraria - Helsinn Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim; Epi-Q; Flatiron Health
Research Funding - Helsinn Therapeutics (Inst); Opus Science/Celgene (Inst)
 
David Rizzieri
Consulting or Advisory Role - Gilead Sciences; incyte; Millennium (I); novartis; onyx (I); pfizer; pharmacyclics; Sanofi; Seagen
Speakers' Bureau - Celgene; Celgene (I); Gilead Sciences; incyte; Millennium (I); Seagen
 
Peter Martin
Honoraria - Janssen
Consulting or Advisory Role - Acerta Pharma; Bayer; Celgene; Gilead Sciences; Janssen; Novartis
Speakers' Bureau - Genentech
Research Funding - Celgene (Inst); Millennium (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Janssen
 
Valerie Mayorga
Research Funding - Janssen Scientific Affairs
 
Katie Deering
Research Funding - Janssen Scientific Affairs
 
Brad Schenkel
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson